Revolution Medicines Earnings
NASDAQ: RVMDHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-2.33
Revolution Medicines earnings summary
Revolution Medicines is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-2.33. In its most recent report on Aug 5, 2026 (Q2 2026), RVMD posted EPS of $-3.06. Across the last 16 reports, RVMD shares moved an average of 5.4% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
RVMD earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $-3.06 | — | -0.7% |
| May 6, 2026 | — | $-2.29 | — | +2.7% |
| Feb 25, 2026 | — | $-1.90 | — | -3.5% |
| Nov 5, 2025 | — | $-1.61 | — | +11.0% |
| Aug 6, 2025 | — | $-1.31 | — | +3.8% |
| May 7, 2025 | — | $-1.13 | — | -2.2% |
| Feb 26, 2025 | — | $-1.13 | — | -3.8% |
| Nov 6, 2024 | — | $-0.94 | — | -8.8% |
| Aug 7, 2024 | — | $-0.81 | — | -0.1% |
| May 8, 2024 | — | $-0.70 | — | +5.8% |
| Feb 26, 2024 | — | $-1.23 | — | +8.2% |
| Nov 6, 2023 | — | $-0.99 | — | +8.2% |
| Aug 8, 2023 | — | $-0.92 | — | -1.2% |
| May 8, 2023 | — | $-0.72 | — | -0.1% |
| Feb 27, 2023 | — | $-0.61 | — | -18.4% |
| Nov 7, 2022 | — | $-0.87 | — | -7.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.